Heterogeneity of ductal carcinoma in sit
โ
Michael D. Lagios
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 395 KB
๐ 1 views
Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents